Simulating a Travel-related Origin of in New York-New Jersey

Overview

Journal Microbiol Spectr

Specialty Microbiology

Date 2024 Dec 19

PMID 39699207

Authors

Rita R Verma

Edward Kiegle

Alexander C Keyel

Sudha Chaturvedi

Vishnu Chaturvedi

Affiliations

Soon will be listed here.

Abstract

Importance: is an emerging fungal pathogen, with resistance to several antifungal drugs. Serious infections affect hospitalized patients and residents of long-term care facilities, although the pathogen can also be present on a healthy individual's skin. Many studies have shown international introductions of to the United States. Here, we present a simulation that supports the hypothesis that the earlier introductions of in the New York-New Jersey area are not random but related to travel networks.

References

Misas E, Escandon P, Gade L, Caceres D, Hurst S, Le N . Genomic epidemiology and antifungal-resistant characterization of , Colombia, 2016-2021. mSphere. 2024; 9(2):e0057723. PMC: 10900874. DOI: 10.1128/msphere.00577-23. View

Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K . Candida auris in Healthcare Facilities, New York, USA, 2013-2017. Emerg Infect Dis. 2018; 24(10):1816-1824. PMC: 6154128. DOI: 10.3201/eid2410.180649. View

Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Kumar Singh P . New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013; 19(10):1670-3. PMC: 3810747. DOI: 10.3201/eid1910.130393. View

Piedrahita C, Cadnum J, Jencson A, Shaikh A, Ghannoum M, Donskey C . Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017; 38(9):1107-1109. DOI: 10.1017/ice.2017.127. View

Borman A, Szekely A, Johnson E . Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol. 2017; 55(5):563-567. DOI: 10.1093/mmy/myw147. View

Casadevall A, Kontoyiannis D, Robert V . Environmental Candida auris and the Global Warming Emergence Hypothesis. mBio. 2021; 12(2). PMC: 8092241. DOI: 10.1128/mBio.00360-21. View

Tsay S, Welsh R, Adams E, Chow N, Gade L, Berkow E . Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017; 66(19):514-515. PMC: 5657645. DOI: 10.15585/mmwr.mm6619a7. View

Adam R, Revathi G, Okinda N, Fontaine M, Shah J, Kagotho E . Analysis of Candida auris fungemia at a single facility in Kenya. Int J Infect Dis. 2019; 85:182-187. DOI: 10.1016/j.ijid.2019.06.001. View

Toda M, Beer K, Kuivila K, Chiller T, Jackson B . Trends in Agricultural Triazole Fungicide Use in the United States, 1992-2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease. Environ Health Perspect. 2021; 129(5):55001. PMC: 8098123. DOI: 10.1289/EHP7484. View

10.

Khan T, Faysal N, Hossain M, Mah-E-Muneer S, Haider A, Moon S . Emergence of the novel sixth Clade VI in Bangladesh. Microbiol Spectr. 2024; 12(7):e0354023. PMC: 11218448. DOI: 10.1128/spectrum.03540-23. View

11.

Zhu Y, OBrien B, Leach L, Clarke A, Bates M, Adams E . Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned. J Clin Microbiol. 2019; 58(4). PMC: 7098748. DOI: 10.1128/JCM.01503-19. View

12.

Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J . Confirmation of fifth clade by whole genome sequencing. Emerg Microbes Infect. 2022; 11(1):2405-2411. PMC: 9586689. DOI: 10.1080/22221751.2022.2125349. View

13.

Dennis E, Chaturvedi S, Chaturvedi V . So Many Diagnostic Tests, So Little Time: Review and Preview of Testing in Clinical and Public Health Laboratories. Front Microbiol. 2021; 12:757835. PMC: 8529189. DOI: 10.3389/fmicb.2021.757835. View

14.

Tan Y, Tan A . Arrival of Fungus in Singapore: Report of the First 3 Cases. Ann Acad Med Singap. 2018; 47(7):260-262. View

15.

Chow N, Munoz J, Gade L, Berkow E, Li X, Welsh R . Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. mBio. 2020; 11(2). PMC: 7188998. DOI: 10.1128/mBio.03364-19. View

16.

Rhodes J, Fisher M . Global epidemiology of emerging Candida auris. Curr Opin Microbiol. 2019; 52:84-89. DOI: 10.1016/j.mib.2019.05.008. View

17.

Suphavilai C, Ko K, Lim K, Tan M, Boonsimma P, Chu J . Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe. 2024; 5(9):100878. DOI: 10.1016/S2666-5247(24)00101-0. View

18.

Lockhart S, Etienne K, Vallabhaneni S, Farooqi J, Chowdhary A, Govender N . Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2016; 64(2):134-140. PMC: 5215215. DOI: 10.1093/cid/ciw691. View

19.

Rhodes J, Abdolrasouli A, Farrer R, Cuomo C, Aanensen D, Armstrong-James D . Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. Emerg Microbes Infect. 2018; 7(1):43. PMC: 5874254. DOI: 10.1038/s41426-018-0045-x. View

20.

Yadav A, Jain K, Wang Y, Pawar K, Kaur H, Sharma K . Candida auris on Apples: Diversity and Clinical Significance. mBio. 2022; 13(2):e0051822. PMC: 9040835. DOI: 10.1128/mbio.00518-22. View